- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05957497
Drone Biological Samples Transport vs Walking (DBT - Drone Biology Transport) (DBT)
Drone Biological Samples Transport Evaluation Compared to Walking in CHU CAEN NORMANDIE
The transport of biological samples is a key step in the pre-analysis process in health facilities and must meet quality requirements (NF:EN:ISO 151989) to ensure that samples are transported in are transported in good conditions.
Still in the experimental stage, drone-based air transport is participating in the aeronautical revolution of the development of unmanned aircraft on board in all areas of society, including health.
This first project, led by the Biology Centre and the INNOVABIO Biological Resources Centre of the CHU de CAEN in collaboration with the company Delivrone, will allow to evaluate the feasibility in real condition of the mode of transport by drone versus transport of reference on the quality of a varied panel of medical biology examinations (biochemistry, hematology and haemostasis), on the safety of people (potentially infectious samples), on the control of the delivery time, on the control of the transport temperature (15-25°C ). The samples will be taken on 30 healthy volunteers with a total panel of 23 blood tests performed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Panel of blood tests performed on healthy volunteers samples include :
- Na, K, Cl, HC03-
- total protein
- Ca
- Creatinine, urea
- Albumine
- Bilirubin
- Liver transaminases (ALT, AST)
- Alkaline phosphatase
- GGT
- LDH
- C-reactive protein
- Complete Blood Count
- Sedimentation rate
- PT
- aPTT
- Fibrinogen
- D-Dimer
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Caen, France, 14000
- CHU Caen Normandie
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy volunteers, over 18 years old
Exclusion Criteria:
- Unhealthy volunteers previously known
- pregnant or breastfeeding woman
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pedestrian transport
Modality of transport currently used
|
Biological samples transport and analysis
|
|
Drone transport
Innovative modality of transport
|
Biological samples transport and analysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impact on Sodium test
Time Frame: 1 day
|
Evaluation difference between results of Sodium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Potassium test
Time Frame: 1 day
|
Evaluation difference between results of Potassium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Chlorure test
Time Frame: 1 day
|
Evaluation difference between results of Chlorure (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Bicarbonate test
Time Frame: 1 day
|
Evaluation difference between results of Bicarbonate (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Protein test
Time Frame: 1 day
|
Evaluation difference between results of Protein (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Calcium test
Time Frame: 1 day
|
Evaluation difference between results of Calcium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Creatinin test
Time Frame: 1 day
|
Evaluation difference between results of Creatinin (µmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Urea test
Time Frame: 1 day
|
Evaluation difference between results of Urea (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Albumin test
Time Frame: 1 day
|
Evaluation difference between results of Albumin (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Bilirubin test
Time Frame: 1 day
|
Evaluation difference between results of Bilirubin (µmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on liver transaminase (ALT) test
Time Frame: 1 day
|
Evaluation difference between results of liver transaminase (ALT, U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on liver transaminase (AST) test
Time Frame: 1 day
|
Evaluation difference between results of liver transaminase (AST, U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on alkalin phosphatase test
Time Frame: 1 day
|
Evaluation difference between results of alkalin phosphatase (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on GGT test
Time Frame: 1 day
|
Evaluation difference between results of GGT (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on LDH test
Time Frame: 1 day
|
Evaluation difference between results of LDH (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on C-reactive Protein test
Time Frame: 1 day
|
Evaluation difference between results of C-reactive Protein (mg/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on red blood cells count
Time Frame: 1 day
|
Evaluation difference between results of red blood cells (T/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on hemoglobin test
Time Frame: 1 day
|
Evaluation difference between results of hemoglobin (g/dL) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on white blood cells count
Time Frame: 1 day
|
Evaluation difference between results of white blood cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on neutrophil cells count
Time Frame: 1 day
|
Evaluation difference between results of neutrophil cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on lymphocytes cells count
Time Frame: 1 day
|
Evaluation difference between results of lymphocytes cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on platelets count
Time Frame: 1 day
|
Evaluation difference between results of platelets (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on sedimentation rate test
Time Frame: 1 day
|
Evaluation difference between results of sedimentation rate (mm) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on PT test
Time Frame: 1 day
|
Evaluation difference between results of PT (sec and %) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on a-PTT test
Time Frame: 1 day
|
Evaluation difference between results of a-PTT (sec) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on Fibrinogen test
Time Frame: 1 day
|
Evaluation difference between results of Fibrinogen (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
|
Impact on D-Dimer test
Time Frame: 1 day
|
Evaluation difference between results of D-Dimer (ng/mL) after drone transport (30 samples) versus pedestrian transport (30 samples).
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the users security
Time Frame: 1 day
|
Report accident of drone or users injuries
|
1 day
|
|
Evaluation of the users safety
Time Frame: 1 day
|
Report numbers of samples broken (contamination risk) after drone transport
|
1 day
|
|
Temperature
Time Frame: 1 day
|
Temperature measurement during the transport.
Evaluation of the ambient temperature respect during the transport in the two conditions.
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Benjamin GILLET, MD, CHU Caen Normandie
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 22-0238
- 2022-A02548-35 (Registry Identifier: ID RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Biological samples transport and analysis
-
Beijing Tiantan HospitalRecruitingGlioma | Brain Tumor | Intracranial Hemorrhages | Intracranial Aneurysm | Carotid Artery StenosisChina
-
Oncology Institute of Southern SwitzerlandClinical Trial Unit Ente Ospedaliero CantonaleRecruitingProstate CancerSwitzerland
-
Meyer Children's Hospital IRCCSRecruitingHematologic Diseases | Oncologic DiseaseItaly
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingAcute Coronary Syndrome | Chronic Coronary SyndromeItaly
-
Meyer Children's Hospital IRCCSRecruitingGenomics | Epigenetic | Pediatric Brain TumorsItaly
-
Meyer Children's Hospital IRCCSRecruitingIBD (Inflammatory Bowel Disease)Italy
-
Qilu Hospital of Shandong UniversityNot yet recruiting
-
Meyer Children's Hospital IRCCSRecruiting
-
Imagine InstituteReference center for rare diseases (Rare Gynecologic Diseases)RecruitingMayer Rokitansky Kuster Hauser SyndromeFrance
-
Velindre NHS TrustNot yet recruiting